Fennec Pharmaceuticals Ownership | Who Owns Fennec Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Fennec Pharmaceuticals Ownership Summary

Fennec Pharmaceuticals is owned by 26.00% institutional investors, 13.41% insiders, and 60.59% retail investors. Southpoint capital advisors lp is the largest institutional shareholder, holding 14.74% of FENC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.20% of its assets in Fennec Pharmaceuticals shares.

FENC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Fennec Pharmaceuticals	26.00%	13.41%	60.59%
Sector	Healthcare Stocks	232.51%	10.72%	-143.22%
Industry	Biotech Stocks	384.55%	10.58%	-295.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Southpoint capital advisors lp	4.08M	14.74%	$38.16M
Rosalind advisors	2.61M	9.37%	$20.12M
Sonic gp	2.41M	8.80%	$15.21M
Solas capital management	2.19M	7.91%	$20.48M
Aigh capital management	1.58M	5.67%	$12.18M
Blackrock funding, inc. /de	1.23M	4.43%	$9.50M
Blackrock	1.19M	4.39%	$7.25M
Vanguard group	1.07M	3.83%	$8.22M
Awm investment company	711.87K	2.55%	$5.48M
State street	341.20K	1.23%	$3.19M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sonic gp	2.41M	33.54%	$15.21M
Solas capital management	2.19M	12.50%	$20.48M
Rosalind advisors	2.61M	7.07%	$20.12M
Lion point capital, lp	123.00K	6.54%	$1.15M
Aigh capital management	1.58M	2.95%	$12.18M
Southpoint capital advisors lp	4.08M	1.00%	$38.16M
Potomac capital management	95.10K	0.59%	$732.27M
Awm investment company	711.87K	0.53%	$5.48M
Tang capital management	334.59K	0.12%	$3.13M
Hartford financial management	50.65K	0.10%	$389.98K

Top Buyers

Holder	Shares	% Assets	Change
Aigh capital management	1.58M	2.95%	900.00K
Awm investment company	711.87K	0.53%	711.87K
Rosalind advisors	2.61M	7.07%	536.67K
Tang capital management	334.59K	0.12%	314.07K
Blackrock	1.19M	0.00%	259.78K

Top Sellers

Holder	Shares	% Assets	Change
Harbert fund advisors	-	-	-177.81K
Essex investment management	-	-	-144.22K
Dg capital management	-	-	-84.21K
Eam investors	-	-	-78.66K
Lion point capital, lp	123.00K	6.54%	-72.70K

New Positions

Holder	Shares	% Assets	Change	Value
Awm investment company	711.87K	0.53%	711.87K	$5.48M
Potomac capital management	95.10K	0.59%	95.10K	$732.27M
Hillsdale investment management	44.00K	0.01%	44.00K	$338.80K
1492 capital management	28.09K	0.08%	28.09K	$216.31K
Xtx topco	21.25K	0.01%	21.25K	$198.87K

Sold Out

Holder	Change
Sbi securities	-1.00
Newedge advisors	-1.00
Nelson, van denburg & campbell wealth management group	-3.00
Capital performance advisors llp	-5.00
Ifp advisors	-7.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	41	-50.60%	7,252,139	-47.69%	26	1.04%	16	-57.89%	9	-62.50%
Sep 30, 2025	37	-48.61%	3,501,549	-73.61%	12	0.55%	10	-73.68%	12	-45.45%
Jun 30, 2025	77	13.24%	13,599,983	1.57%	49	2.09%	40	33.33%	24	20.00%
Mar 31, 2025	5	-92.19%	4,328,394	-73.03%	15	0.46%	2	-94.87%	1	-92.31%
Dec 31, 2024	31	-50.00%	4,180,599	-72.00%	15	0.51%	23	-30.30%	4	-73.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	882.05K	3.20%	5.84K
Vanguard Total Stock Mkt Idx Inv	776.33K	2.81%	-17.09K
iShares Russell 2000 ETF	539.23K	1.94%	-
Fidelity Small Cap Index	234.34K	0.84%	-6.71K
iShares Russell 2000 Value ETF	149.01K	0.54%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	122.70K	0.44%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	122.70K	0.44%	-
Vanguard Russell 2000 ETF	111.76K	0.40%	-7.55K
State St Russell Sm Cap® Indx SL Cl I	69.00K	0.25%	-
Schwab Small Cap Index	61.29K	0.22%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 02, 2026	Raykov Rosty	-	Sell	$80.31K
Jan 02, 2026	Raykov Rosty	-	Sell	$78.37K
Dec 24, 2025	Southpoint Capital Advisors LP	-	Sell	$7.50M
Dec 05, 2025	Raykov Rosty	-	Sell	$75.40K
Nov 18, 2025	Southpoint Capital Advisors LP	-	Sell	$170.05K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	2
2025 Q4	-	11
2025 Q3	-	4
2024 Q4	-	1
2024 Q3	-	4

FENC Ownership FAQ

Who Owns Fennec Pharmaceuticals?

Fennec Pharmaceuticals shareholders are primarily institutional investors at 26.00%, followed by 13.41% insiders and 60.59% retail investors. The average institutional ownership in Fennec Pharmaceuticals's industry, Biotech Stocks , is 384.55%, which Fennec Pharmaceuticals falls below.

Who owns the most shares of Fennec Pharmaceuticals?

Fennec Pharmaceuticals’s largest shareholders are Southpoint capital advisors lp (4.08M shares, 14.74%), Rosalind advisors (2.61M shares, 9.37%), and Sonic gp (2.41M shares, 8.80%). Together, they hold 32.90% of Fennec Pharmaceuticals’s total shares outstanding.

Does Blackrock own Fennec Pharmaceuticals?

Yes, BlackRock owns 4.39% of Fennec Pharmaceuticals, totaling 1.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.25M$. In the last quarter, BlackRock increased its holdings by 259.78K shares, a 28.01% change.

Who is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sonic gp is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 33.54% of its assets in 2.41M Fennec Pharmaceuticals shares, valued at 15.21M$.

Who is the top mutual fund holder of Fennec Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Fennec Pharmaceuticals shares, with 3.20% of its total shares outstanding invested in 882.05K Fennec Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools